Differential requirement for c-jun N-terminal kinase 1 in lung inflammation and host defense

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  van der Velden, Jos ^a   Janssen Heininger, Yvonne M W ^a   Mandalapu, Sivanarayna ^b   Scheller, Erich V ^b   Kolls, Jay K ^b   Alcorn, John F ^b  

^a UNIVERSITY OF VERMONT   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; KERATINOCYTE DERIVED CHEMOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; POLYPEPTIDE ANTIBIOTIC AGENT; STRESS ACTIVATED PROTEIN KINASE 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL PNEUMONIA; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG TARGETING; ENZYME ACTIVITY; EPITHELIUM CELL; ESCHERICHIA COLI; GENE DELETION; HISTOPATHOLOGY; HOST RESISTANCE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; INFLUENZA A; INNATE IMMUNITY; MORBIDITY; MOUSE; NONHUMAN; PATHOGEN CLEARANCE; PATHOPHYSIOLOGY; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; VIRUS PNEUMONIA; WILD TYPE; ANIMAL; CELL CULTURE; IMMUNOLOGY; LUNG; METABOLISM; MICROBIOLOGY; MOUSE MUTANT; PATHOGENICITY; PHYSIOLOGY; PNEUMONIA;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MUS; STAPHYLOCOCCUS AUREUS;

ANIMALS; CELLS, CULTURED; INTERLEUKIN-17; LUNG; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 8; PNEUMONIA; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS;

EID: 84859726335     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034638     Document Type: Article

References (48)

1. Rincon M, Pedraza-Alva G, (2003) JNK and p38 MAP kinases in CD4+ and CD8+ T cells. Immunol Rev 192: 131-142.
2. Weston CR, Davis RJ, (2007) The JNK signal transduction pathway. Curr Opin Cell Biol 19: 142-149.
3. Alcorn JF, Guala AS, van der Velden J, McElhinney B, Irvin CG, et al. (2008) Jun N-terminal kinase 1 regulates epithelial-to-mesenchymal transition induced by TGF-beta1. J Cell Sci 121: 1036-1045.
4. Alcorn JF, van der Velden J, Brown AL, McElhinney B, Irvin CG, et al. (2009) c-Jun N-terminal kinase 1 is required for the development of pulmonary fibrosis. Am J Respir Cell Mol Biol 40: 422-432.
5. Velden JL, Alcorn JF, Guala AS, Badura EC, Janssen-Heininger YM, (2011) c-Jun N-terminal kinase 1 promotes transforming growth factor-beta1-induced epithelial-to-mesenchymal transition via control of linker phosphorylation and transcriptional activity of Smad3. Am J Respir Cell Mol Biol 44: 571-581.
6. Dong C, Davis RJ, Flavell RA, (2002) MAP kinases in the immune response. Annu Rev Immunol 20: 55-72.
7. Rincon M, Davis RJ, (2009) Regulation of the immune response by stress-activated protein kinases. Immunol Rev 228: 212-224.
8. Guha M, Mackman N, (2001) LPS induction of gene expression in human monocytes. Cell Signal 13: 85-94.
9. Guillot L, Medjane S, Le-Barillec K, Balloy V, Danel C, et al. (2004) Response of human pulmonary epithelial cells to lipopolysaccharide involves Toll-like receptor 4 (TLR4)-dependent signaling pathways: evidence for an intracellular compartmentalization of TLR4. J Biol Chem 279: 2712-2718.
10. Cuzick A, Stirling FR, Lindsay SL, Evans TJ, (2006) The type III pseudomonal exotoxin U activates the c-Jun NH2-terminal kinase pathway and increases human epithelial interleukin-8 production. Infect Immun 74: 4104-4113.
11. Wang J, Gigliotti F, Bhagwat SP, Maggirwar SB, Wright TW, (2007) Pneumocystis stimulates MCP-1 production by alveolar epithelial cells through a JNK-dependent mechanism. Am J Physiol Lung Cell Mol Physiol 292: L1495-1505.
12. Christiansen D, Brekke OL, Stenvik J, Lambris JD, Espevik T, et al. (2012) Differential effect of inhibiting MD-2 and CD14 on LPS- versus whole E. coli bacteria-induced cytokine responses in human blood. Adv Exp Med Biol 946: 237-251.
13. Fournier B, Philpott DJ, (2005) Recognition of Staphylococcus aureus by the innate immune system. Clin Microbiol Rev 18: 521-540.
14. Crowe CR, Chen K, Pociask DA, Alcorn JF, Krivich C, et al. (2009) Critical role of IL-17RA in immunopathology of influenza infection. J Immunol 183: 5301-5310.
15. Kudva A, Scheller EV, Robinson KM, Crowe CR, Choi SM, et al. (2011) Influenza A inhibits Th17-mediated host defense against bacterial pneumonia in mice. J Immunol 186: 1666-1674.
16. Ye P, Garvey PB, Zhang P, Nelson S, Bagby G, et al. (2001) Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am J Respir Cell Mol Biol 25: 335-340.
17. Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, et al. (2001) Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 194: 519-527.
18. Baranova IN, Kurlander R, Bocharov AV, Vishnyakova TG, Chen Z, et al. (2008) Role of human CD36 in bacterial recognition, phagocytosis, and pathogen-induced JNK-mediated signaling. J Immunol 181: 7147-7156.
19. Jia J, Wang Y, Zhou L, Jin S, (2006) Expression of Pseudomonas aeruginosa toxin ExoS effectively induces apoptosis in host cells. Infect Immun 74: 6557-6570.
20. Liu W, Ouyang X, Yang J, Liu J, Li Q, et al. (2009) AP-1 activated by toll-like receptors regulates expression of IL-23 p19. J Biol Chem 284: 24006-24016.
21. Jeyaseelan S, Young SK, Fessler MB, Liu Y, Malcolm KC, et al. (2007) Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF)-mediated signaling contributes to innate immune responses in the lung during Escherichia coli pneumonia. J Immunol 178: 3153-3160.
22. Balamayooran G, Batra S, Balamayooran T, Cai S, Jeyaseelan S, (2011) Monocyte chemoattractant protein 1 regulates pulmonary host defense via neutrophil recruitment during Escherichia coli infection. Infect Immun 79: 2567-2577.
23. Prause O, Bossios A, Silverpil E, Ivanov S, Bozinovski S, et al. (2009) IL-17-producing T lymphocytes in lung tissue and in the bronchoalveolar space after exposure to endotoxin from Escherichia coli in vivo-effects of anti-inflammatory pharmacotherapy. Pulm Pharmacol Ther 22: 199-207.
24. Sivick KE, Schaller MA, Smith SN, Mobley HL, (2010) The innate immune response to uropathogenic Escherichia coli involves IL-17A in a murine model of urinary tract infection. J Immunol 184: 2065-2075.
25. Balamayooran T, Batra S, Balamayooran G, Cai S, Kobayashi KS, et al. (2011) Receptor-interacting protein 2 controls pulmonary host defense to Escherichia coli infection via the regulation of interleukin-17A. Infect Immun 79: 4588-4599.
26. Cheon IS, Woo SS, Kang SS, Im J, Yun CH, et al. (2008) Peptidoglycan-mediated IL-8 expression in human alveolar type II epithelial cells requires lipid raft formation and MAPK activation. Mol Immunol 45: 1665-1673.
27. Lu X, Masic A, Li Y, Shin Y, Liu Q, et al. (2010) The PI3K/Akt pathway inhibits influenza A virus-induced Bax-mediated apoptosis by negatively regulating the JNK pathway via ASK1. J Gen Virol 91: 1439-1449.
28. Ludwig S, Wang X, Ehrhardt C, Zheng H, Donelan N, et al. (2002) The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors. J Virol 76: 11166-11171.
29. Desmet EA, Hollenbaugh JA, Sime PJ, Wright TW, Topham DJ, et al. (2010) Mixed Lineage Kinase 3 deficiency delays viral clearance in the lung and is associated with diminished influenza-induced cytopathic effect in infected cells. Virology 400: 224-232.
30. Kujime K, Hashimoto S, Gon Y, Shimizu K, Horie T, (2000) p38 mitogen-activated protein kinase and c-jun-NH2-terminal kinase regulate RANTES production by influenza virus-infected human bronchial epithelial cells. J Immunol 164: 3222-3228.
31. Ludwig S, Ehrhardt C, Neumeier ER, Kracht M, Rapp UR, et al. (2001) Influenza virus-induced AP-1-dependent gene expression requires activation of the JNK signaling pathway. J Biol Chem 276: 10990-10998.
32. Wu W, Booth JL, Duggan ES, Wu S, Patel KB, et al. (2010) Innate immune response to H3N2 and H1N1 influenza virus infection in a human lung organ culture model. Virology 396: 178-188.
33. Hayashi S, Jibiki I, Asai Y, Gon Y, Kobayashi T, et al. (2008) Analysis of gene expression in human bronchial epithelial cells upon influenza virus infection and regulation by p38 mitogen-activated protein kinase and c-Jun-N-terminal kinase. Respirology 13: 203-214.
34. Conze D, Krahl T, Kennedy N, Weiss L, Lumsden J, et al. (2002) c-Jun NH(2)-terminal kinase (JNK)1 and JNK2 have distinct roles in CD8(+) T cell activation. J Exp Med 195: 811-823.
35. Mehrotra S, Chhabra A, Hegde U, Chakraborty NG, Mukherji B, (2007) Inhibition of c-Jun N-terminal kinase rescues influenza epitope-specific human cytolytic T lymphocytes from activation-induced cell death. J Leukoc Biol 81: 539-547.
36. de Haij S, Bakker AC, van der Geest RN, Haegeman G, Vanden Berghe W, et al. (2005) NF-kappaB mediated IL-6 production by renal epithelial cells is regulated by c-jun NH2-terminal kinase. J Am Soc Nephrol 16: 1603-1611.
37. Rahman MS, Yamasaki A, Yang J, Shan L, Halayko AJ, et al. (2006) IL-17A induces eotaxin-1/CC chemokine ligand 11 expression in human airway smooth muscle cells: role of MAPK (Erk1/2, JNK, and p38) pathways. J Immunol 177: 4064-4071.
38. Wuyts WA, Vanaudenaerde BM, Dupont LJ, van Raemdonck DE, Demedts MG, et al. (2005) Interleukin-17-induced interleukin-8 release in human airway smooth muscle cells: role for mitogen-activated kinases and nuclear factor-kappaB. J Heart Lung Transplant 24: 875-881.
39. Yagi Y, Andoh A, Inatomi O, Tsujikawa T, Fujiyama Y, (2007) Inflammatory responses induced by interleukin-17 family members in human colonic subepithelial myofibroblasts. J Gastroenterol 42: 746-753.
40. Zhou Y, Toh ML, Zrioual S, Miossec P, (2007) IL-17A versus IL-17F induced intracellular signal transduction pathways and modulation by IL-17RA and IL-17RC RNA interference in AGS gastric adenocarcinoma cells. Cytokine 38: 157-164.
41. Ma X, Reynolds SL, Baker BJ, Li X, Benveniste EN, et al. (2010) IL-17 enhancement of the IL-6 signaling cascade in astrocytes. J Immunol 184: 4898-4906.
42. Schwandner R, Yamaguchi K, Cao Z, (2000) Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction. J Exp Med 191: 1233-1240.
43. Shahrara S, Pickens SR, Mandelin AM 2nd, Karpus WJ, Huang Q, et al. (2010) IL-17-mediated monocyte migration occurs partially through CC chemokine ligand 2/monocyte chemoattractant protein-1 induction. J Immunol 184: 4479-4487.
44. Wiehler S, Proud D, (2007) Interleukin-17A modulates human airway epithelial responses to human rhinovirus infection. Am J Physiol Lung Cell Mol Physiol 293: L505-515.
45. Kawaguchi M, Kokubu F, Kuga H, Matsukura S, Hoshino H, et al. (2001) Modulation of bronchial epithelial cells by IL-17. J Allergy Clin Immunol 108: 804-809.
46. Kawaguchi M, Onuchic LF, Huang SK, (2002) Activation of extracellular signal-regulated kinase (ERK)1/2, but not p38 and c-Jun N-terminal kinase, is involved in signaling of a novel cytokine, ML-1. J Biol Chem 277: 15229-15232.
47. Shen F, Hu Z, Goswami J, Gaffen SL, (2006) Identification of common transcriptional regulatory elements in interleukin-17 target genes. J Biol Chem 281: 24138-24148.
48. Dong C, Yang DD, Wysk M, Whitmarsh AJ, Davis RJ, et al. (1998) Defective T cell differentiation in the absence of Jnk1. Science 282: 2092-2095.